EMAIL THIS PAGE TO A FRIEND

Journal of lipid research

Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells.


PMID 26089538

Abstract

Two APOL1 gene variants, which likely evolved to protect individuals from African sleeping sickness, are strongly associated with nondiabetic kidney disease in individuals with recent African ancestry. Consistent with its role in trypanosome killing, the pro-death APOL1 protein is toxic to most cells, but its mechanism of cell death is poorly understood and little is known regarding its intracellular trafficking and secretion. Because the liver appears to be the main source of circulating APOL1, we examined its secretory behavior and mechanism of toxicity in hepatoma cells and primary human hepatocytes. APOL1 is poorly secreted in vitro, even in the presence of chemical chaper-ones; however, it is efficiently secreted in wild-type transgenic mice, suggesting that APOL1 secretion has specialized requirements that cultured cells fail to support. In hepatoma cells, inducible expression of APOL1 and its risk variants promoted cell death, with the G1 variant displaying the highest degree of toxicity. To explore the basis for APOL1-mediated cell toxicity, endoplasmic reticulum stress, pyroptosis, autophagy, and apoptosis were examined. Our results suggest that autophagy represents the predominant mechanism of APOL1-mediated cell death. Overall, these results increase our understanding of the basic biology and trafficking behavior of circulating APOL1 from the liver.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2100099
Anti-ALB (ab2) antibody produced in rabbit, affinity isolated antibody
HPA018885
Anti-APOL1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104172
Anti-MBP antibody produced in rabbit, affinity isolated antibody
HPA049222
Anti-MBP antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
F5262 Anti-Mouse IgG (Fab specific)−FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F4018 Anti-Mouse IgG (Fab specific)−FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F8771 Anti-Mouse IgG (Fab specific)−FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F5387 Anti-Mouse IgG (Fc specific)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F4143 Anti-Mouse IgG (Fc specific)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F5897 Anti-Mouse IgG (Fc specific)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F8264 Anti-Mouse IgG (γ-chain specific)−FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F0257
Anti-Mouse IgG (whole molecule)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F2012
Anti-Mouse IgG (whole molecule)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F9006 Anti-Mouse IgG (whole molecule)–FITC antibody produced in goat, IgG fraction of antiserum, buffered aqueous solution
M3821 Anti-Myelin Basic Protein (MBP) antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
WH0000213M1
Monoclonal Anti-ALB antibody produced in mouse, clone 1G12-1B3, purified immunoglobulin, buffered aqueous solution